183 related articles for article (PubMed ID: 32513905)
1. Monitoring Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using
Sharma R; Inglese M; Dubash S; Lu H; Pinato DJ; Sanghera C; Patel N; Chung A; Tait PD; Mauri F; Crum WR; Barwick TD; Aboagye EO
J Nucl Med; 2020 Dec; 61(12):1743-1748. PubMed ID: 32513905
[TBL] [Abstract][Full Text] [Related]
2. Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidine.
Eckel F; Herrmann K; Schmidt S; Hillerer C; Wieder HA; Krause BJ; Schuster T; Langer R; Wester HJ; Schmid RM; Schwaiger M; Buck AK
J Nucl Med; 2009 Sep; 50(9):1441-7. PubMed ID: 19690030
[TBL] [Abstract][Full Text] [Related]
3. The value of [
Li S; Peck-Radosavljevic M; Ubl P; Wadsak W; Mitterhauser M; Rainer E; Pinter M; Wang H; Nanoff C; Kaczirek K; Haug A; Hacker M
Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1732-1741. PubMed ID: 28555333
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of 18F-FDG PET/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE).
Ma W; Jia J; Wang S; Bai W; Yi J; Bai M; Quan Z; Yin Z; Fan D; Wang J; Han G
Theranostics; 2014; 4(7):736-44. PubMed ID: 24883123
[TBL] [Abstract][Full Text] [Related]
5. Imaging of cellular proliferation in liver metastasis by [18F]fluorothymidine positron emission tomography: effect of therapy.
Contractor K; Challapalli A; Tomasi G; Rosso L; Wasan H; Stebbing J; Kenny L; Mangar S; Riddle P; Palmieri C; Al-Nahhas A; Sharma R; Turkheimer F; Coombes RC; Aboagye E
Phys Med Biol; 2012 Jun; 57(11):3419-33. PubMed ID: 22572708
[TBL] [Abstract][Full Text] [Related]
6. 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization.
Park S; Kim TS; Kang SH; Kim HB; Park JW; Kim SK
Medicine (Baltimore); 2018 Sep; 97(37):e12311. PubMed ID: 30212970
[TBL] [Abstract][Full Text] [Related]
7. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K
Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
[TBL] [Abstract][Full Text] [Related]
8. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.
Chen G; Ma DQ; He W; Zhang BF; Zhao LQ
World J Gastroenterol; 2008 Oct; 14(37):5738-43. PubMed ID: 18837093
[TBL] [Abstract][Full Text] [Related]
9. Imaging Changes and Clinical Complications After Drug-Eluting Bead Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study.
Zhang L; Sun JH; Ji JS; Zhong BY; Zhou GH; Song JJ; Hou ZH; Huang P; Zhang S; Li Z; Zhu XL; Ni CF
AJR Am J Roentgenol; 2021 Oct; 217(4):933-943. PubMed ID: 33245680
[No Abstract] [Full Text] [Related]
10. Prognostic Value of 18-Fluorodeoxyglucose-Positron Emission Tomography After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma Undergoing Orthotopic Liver Transplantation.
Cascales-Campos PA; Ramírez P; Lopez V; Gonzalez R; Saenz-Mateos L; Llacer E; Sánchez Bueno F; Robles R; Pons JA; Capel A; Frutos L; Navarro JL; Muñoz-Ramon P; Parrilla P
Transplant Proc; 2015 Oct; 47(8):2374-6. PubMed ID: 26518931
[TBL] [Abstract][Full Text] [Related]
11. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.
Kaufmann S; Schulze M; Spira D; Horger M
Acta Radiol; 2016 Jan; 57(1):8-12. PubMed ID: 25585848
[TBL] [Abstract][Full Text] [Related]
12. Value of 18-FDG-positron emission tomography/computed tomography before and after transarterial chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: initial results.
Cascales Campos P; Ramirez P; Gonzalez R; Febrero B; Pons JA; Miras M; Sanchez Bueno F; Robles R; Parrilla P
Transplant Proc; 2011; 43(6):2213-5. PubMed ID: 21839236
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
Lee JW; Yun M; Cho A; Han KH; Kim DY; Lee SM; Lee JD
Ann Nucl Med; 2015 Jun; 29(5):400-8. PubMed ID: 25652647
[TBL] [Abstract][Full Text] [Related]
14. Use of (18)F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization.
Kim MJ; Kim YS; Cho YH; Jang HY; Song JY; Lee SH; Jeong SW; Kim SG; Jang JY; Kim HS; Kim BS; Lee WH; Park JM; Lee JM; Lee MH; Choi DL
Korean J Intern Med; 2015 May; 30(3):308-15. PubMed ID: 25995661
[TBL] [Abstract][Full Text] [Related]
15. Role of intravoxel incoherent motion (IVIM) imaging in response assessment of hepatocellular carcinoma after transarterial chemoembolization (TACE) - A prospective study.
Reddy Bursapalle M; Valakkadaa J; Ayappan A
Radiologia (Engl Ed); 2024; 66(1):23-31. PubMed ID: 38365352
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of ¹⁸F-FDG Uptake in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization or Concurrent Chemoradiotherapy: A Multicenter Retrospective Cohort Study.
Lee JW; Oh JK; Chung YA; Na SJ; Hyun SH; Hong IK; Eo JS; Song BI; Kim TS; Kim DY; Kim SU; Moon DH; Lee JD; Yun M
J Nucl Med; 2016 Apr; 57(4):509-16. PubMed ID: 26742711
[TBL] [Abstract][Full Text] [Related]
17. Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC): long-term results from a single-center 137-patient cohort prospective study.
Orlacchio A; Chegai F; Roma S; Merolla S; Bosa A; Francioso S
Radiol Med; 2020 Jan; 125(1):98-106. PubMed ID: 31583558
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of metabolic characteristics and viability of lipiodolized hepatocellular carcinomas using 18F-FDG PET/CT.
Kim HO; Kim JS; Shin YM; Ryu JS; Lee YS; Lee SG
J Nucl Med; 2010 Dec; 51(12):1849-56. PubMed ID: 21098794
[TBL] [Abstract][Full Text] [Related]
20. Computed tomographic perfusion with 160-mm coverage: comparative analysis of hepatocellular carcinoma treated by two transarterial chemoembolization courses relative to magnetic resonance imaging findings.
Bayle M; Clerc-Urmès I; Ayav A; Bronowicki JP; Petit I; Orry X; Laurent V
Abdom Radiol (NY); 2019 Jan; 44(1):85-94. PubMed ID: 30054686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
